Comparing Out-of-Pocket Costs and Health-Related Quality of Life Between Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes
Sisi Hu,1 Preeti Pushpalata Zanwar,1– 3 Tara Jenkins,1 Rajkumar J Sevak,1 Bhaskara R Jasti1 1Thomas J. Long School of Pharmacy, University of the Pacific, Stockton, CA, USA; 2Thomas Jefferson University, Philadelphia, PA, USA; 3Texas A&M University, College Station & Kingsville, Kingsville,...
Saved in:
| Main Authors: | Hu S, Zanwar PP, Jenkins T, Sevak RJ, Jasti BR |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Drug, Healthcare and Patient Safety |
| Subjects: | |
| Online Access: | https://www.dovepress.com/comparing-out-of-pocket-costs-and-health-related-quality-of-life-betwe-peer-reviewed-fulltext-article-DHPS |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of sex on sodium‐glucose co‐transporter‐2 antagonists and glucagon‐like peptide‐1 agonists in heart failure
by: Mevin A. Philip, et al.
Published: (2024-12-01) -
Risk of Hearing Loss in Patients Treated with Exendin-4 Derivatives: A Network Meta-Analysis of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter 2 Inhibitors
by: Jiann-Jy Chen, et al.
Published: (2025-05-01) -
Out of pocket and catastrophic health expenditure in Tanzania: recent evidence on the incidence, intensity and distribution
by: John Massito, et al.
Published: (2025-05-01) -
Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01) -
Comparative effectiveness and safety of sodium-glucose cotransporter 2 inhibitors vs glucagon-like peptide 1 receptor agonists in elderly patients with type 2 diabetes mellitus: a meta-analysis
by: Yao Wang, et al.
Published: (2025-08-01)